Medical Director, Radiation Oncology, Fred Hutch Professor, Vice Chair of Faculty Affairs, Clinical Research Director, Division of Radiation Oncology, University of Washington School of Medicine ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. Melanoma, the deadliest ...

“It had started to grow and become oddly shaped, and the doctor removed it, sent it away, and it came back as just a really light or early form of stage one skin cancer, melanoma.” Schneider ...

Their study shows that blocking MARCO in combination with a type of immunotherapy known as anti-CTLA4 therapy, significantly enhances tumor regression in melanoma, the deadliest form of skin cancer.